BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R, Ghasemnejad T. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022;19:92. [PMID: 35619180 DOI: 10.1186/s12985-022-01814-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Korobova ZR, Arsentieva NA, Liubimova NE, Batsunov OK, Dedkov VG, Gladkikh AS, Sharova AA, Adish Z, Chernykh EI, Kaschenko VA, Ratnikov VA, Gorelov VP, Stanevich OV, Kulikov AN, Pevtsov DE, Totolian AA. Cytokine Profiling in Different SARS-CoV-2 Genetic Variants. IJMS 2022;23:14146. [DOI: 10.3390/ijms232214146] [Reference Citation Analysis]
2 Hamed RM, Mahmood MM, Ad'hiah AH. Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech). Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.11.002] [Reference Citation Analysis]
3 Ma H, Murphy C, Loscher CE, O’kennedy R. Autoantibodies - enemies, and/or potential allies? Front Immunol 2022;13:953726. [DOI: 10.3389/fimmu.2022.953726] [Reference Citation Analysis]
4 Aramini B, Masciale V, Samarelli AV, Tonelli R, Cerri S, Clini E, Stella F, Dominici M. Biological effects of COVID-19 on lung cancer: Can we drive our decisions. Front Oncol 2022;12:1029830. [DOI: 10.3389/fonc.2022.1029830] [Reference Citation Analysis]
5 Alvarez M, Trent E, Goncalves BDS, Pereira DG, Puri R, Frazier NA, Sodhi K, Pillai SS. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci 2022;14:1020092. [DOI: 10.3389/fnagi.2022.1020092] [Reference Citation Analysis]
6 Huang WT, Weng SW, Tzeng HT, Yen FC, Chiang YS, You HL. Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination. Vaccines (Basel) 2022;10:1550. [PMID: 36146627 DOI: 10.3390/vaccines10091550] [Reference Citation Analysis]
7 Pál K, Molnar AA, Huțanu A, Szederjesi J, Branea I, Timár Á, Dobreanu M. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. IJMS 2022;23:10423. [DOI: 10.3390/ijms231810423] [Reference Citation Analysis]
8 Dybowska M, Wyrostkiewicz D, Opoka L, Lewandowska K, Sobiecka M, Tomkowski W, Szturmowicz M. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis. IJMS 2022;23:10372. [DOI: 10.3390/ijms231810372] [Reference Citation Analysis]
9 Khalilzadeh F, Sakhaee F, Sotoodehnejadnematalahi F, Zamani MS, Ahmadi I, Anvari E, Fateh A. Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population. Int J Immunogenet 2022. [PMID: 36029284 DOI: 10.1111/iji.12598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Moatar AI, Chis AR, Marian C, Sirbu I. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. IJMS 2022;23:9239. [DOI: 10.3390/ijms23169239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Mongkolsucharitkul P, Surawit A, Pumeiam S, Sookrung N, Tungtrongchitr A, Phisalprapa P, Sayabovorn N, Srivanichakorn W, Washirasaksiri C, Auesomwang C, Sitasuwan T, Chaisathaphol T, Tinmanee R, Chayakulkeeree M, Phoompoung P, Tangjittipokin W, Senawong S, Sanpawitayakul G, Muangman S, Mayurasakorn K, On Behalf Of The Siriraj Population Health And Nutrition Research Sphere Group. SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand. Vaccines (Basel) 2022;10:1131. [PMID: 35891295 DOI: 10.3390/vaccines10071131] [Reference Citation Analysis]
12 Malekinejad Z, Baghbanzadeh A, Nakhlband A, Baradaran B, Jafari S, Bagheri Y, Raei F, Montazersaheb S, Farahzadi R. Recent clinical findings on the role of kinase inhibitors in COVID-19 management. Life Sci 2022;306:120809. [PMID: 35841979 DOI: 10.1016/j.lfs.2022.120809] [Reference Citation Analysis]